Rheumatoid Arthritis Virtual Grand Rounds
   
Sessions

Print this Content

 

Conversations With Patients About Rheumatoid Arthritis, Cancer, and Biologics
John J. Cush, MD
Baylor University Medical Center
Patient Registries in Rheumatoid Arthritis: Opportunities and Challenges for Rheumatologists
Jeffrey Greenberg, MD, MPH
New York University School of Medicine
Managing Risk in Patients with RA: Focus on Demyelinating Conditions
Leonard Calabrese, DO
Cleveland Clinic
The Emerging Role of Electronic Health Records in the Care of Patients with Rheumatoid Arthritis
Peter J. Embi, MD, MS
University of Cincinnati
Long-Term Safety and Efficacy of DMARDs and Biologics in the Treatment of Rheumatoid Arthritis
Roy Fleischmann, MD
University of Texas Southwestern Medical Center
Metroplex Clinical Research Center
The Difficult RA Case: Inadequate Response to One or More Biologics
Michael H. Schiff, MD
University of Colorado School of Medicine
Fall 2009 Conference Update: What's New in Biologics
Philip J. Mease, MD
Swedish Medical Center
Immunizations in Autoimmune Disease
Clifton O. Bingham III, MD
Johns Hopkins University

Comorbidity in Patients with Rheumatoid Arthritis: What are the Real Concerns?
Stephen Paget, MD, FACP, FACR
Weill Cornell Medical College

Quantitatively-Driven Management of Rheumatoid Arthritis
Jonathan Kay, MD
University of Massachusetts Medical School

Applying Research to Your Practice: Focus on Nonbiologic DMARDs in 2009
Yusuf Yazici, MD
NYU Hospital for Joint Diseases

Rheumatoid Arthritis: The Heart of the Matter Assessing Cardiovascular Risk in Patients with Rheumatoid Arthritis
M. Elaine Husni, MD MPH
Cleveland Clinic, Cleveland Ohio

The Application of New ACR Recommendations in the Management of Rheumatoid Arthritis: A Case Study Approach
Kenneth G. Saag, MD, MSc
University of Alabama at Birmingham, Birmingham, Alabama

Safety of Novel Immunomodulatory Therapies
Arthur Kavanaugh, MD
University of California, San Diego

Failing a TNF Inhibitor: What About Switching?
Yusuf Yazici, MD
NYU Hospital for Joint Diseases

 

 
Richard J Fasenmyer Center for Clinical Immunology